Today: 8 June 2026
Ramelius Resources share price: buyback update, director sale and UBS call set the next trade
24 February 2026
1 min read

Ramelius Resources share price: buyback update, director sale and UBS call set the next trade

Sydney, February 24, 2026, 18:33 AEDT — Market closed

  • Ramelius Resources closed at A$4.87 after a 0.2% dip, the stock riding through some sharp intraday moves.
  • The miner’s latest repurchase filing shows 1.24 million shares bought back, with about A$5.56 million spent.
  • Traders are watching buybacks, upcoming mining milestones, and when the March dividend will hit.

Ramelius Resources Limited (ASX:RMS) closed Tuesday barely changed, with investors digesting an on-market share buyback update and news of a director selling shares. The stock ended at A$4.87, down a single cent from its previous finish. It kicked off the session at A$5.08.

The buyback is grabbing attention—management can pull the trigger fast if cash builds and trading gets choppy. In gold mining, moods turn sharply with bullion swings and shifting risk appetite. Repurchasing soaks up shares when prices sag.

It’s a busy stretch for Australian resources names, as investors juggle the prospect of cash payouts against growth spending. Ramelius is offering up dividends and buybacks, while also signaling it’s ready to invest in expansion. The market still has to decide what wins out if costs climb or gold prices slip.

In an ASX Appendix 3C lodged Feb. 23, Ramelius said it bought back 1,235,503 shares on Feb. 20, spending about A$5.56 million, with shares trading between A$4.43 and A$4.60. That leaves 72,569,626 shares available under the buyback program, which originally allowed for up to 73,964,497 shares.

Non-executive director Fiona Jane Murdoch offloaded 74,200 shares in on-market trades at A$4.69 apiece on Feb. 23, an ASX filing shows. Her remaining indirect holding is now 4,000 shares.

UBS upgraded Ramelius to “Buy” from “Neutral,” leaving its A$5.20 price target unchanged. The move follows a larger-than-expected interim dividend and a faster production ramp-up, which comes despite a recent pinch in free cash flow tied to investment. UBS still sees first stoping at Never Never underground starting sometime between March and April. FNArena.com

In February, Ramelius used a conference stage to pitch its bigger-picture goals, targeting more than 500,000 ounces in yearly output by FY30. Management highlighted healthy cash and gold reserves, circling back to shareholder returns and the headline A$250 million buyback. The term “AISC” also surfaced, with the company marking all-in sustaining cost as its go-to metric for stacking up against competitors.

Gold’s peers usually run together when bullion starts moving, but the group rarely stays unified for long. Investors start to splinter, zeroing in on delivery risks, how costs stack up, and whether the so-called “growth story” is more than just extra leverage in disguise.

Buybacks can disappear overnight; nothing guarantees they’ll stick around. Shares jump, or a company faces heftier spending needs, and those repurchases can vanish just as quickly. Throw in even small director sales, and in a jumpy market, you’ll see fresh volatility.

The dividend timeline is next up for investors. Market Index puts the interim dividend ex-date at March 16, with payouts to follow on April 15. April 28 is when the next quarterly report is due.

Stock Market Today

  • Markets Jitter Over Iran Conflict, AI Bubble Risks, Fed Rate Hikes, and SpaceX IPO
    June 8, 2026, 6:02 AM EDT. Markets face heightened volatility as renewed Iran-Israel tensions raise geopolitical risks. Strong U.S. jobs data suggest the Federal Reserve may hike interest rates further, dampening growth prospects. Recent weak guidance from Broadcom signals a potential AI tech bubble burst, triggering a tech selloff. Adding fuel, SpaceX's highly anticipated IPO could prompt investors to raise cash, potentially increasing market turbulence. Futures on the Dow, S&P 500, and Nasdaq all declined slightly, while oil prices surged over 2.5%, reflecting geopolitical concerns. Investors remain cautious as upcoming inflation reports may influence future Federal Reserve policy and market direction.

Latest articles

Asia Markets: Kospi Selloff Hits AI Shares in Region

Asia Markets: Kospi Selloff Hits AI Shares in Region

8 June 2026
South Korea’s KOSPI plunged 8.3%—triggering circuit breakers—as investors dumped AI chip stocks like Samsung Electronics (-10.2%) and SK Hynix (-7.7%) amid surging oil prices and revived Fed rate-hike bets, exposing Asia’s heavy reliance on a handful of tech giants and raising fresh risks for crowded trades.
Keel Stock in Focus Monday After $400M AI Debt Raise

Keel Stock in Focus Monday After $400M AI Debt Raise

8 June 2026
Keel Infrastructure shares rose 3.1% to $5.29 in pre-market trading after pricing an upsized $400 million convertible note deal to fund AI data-center expansion, partially recovering from Friday’s 13.5% drop driven by dilution concerns; the company aims to use proceeds for equipment deposits and hedging, with investors watching for future lease signings as the next key milestone.
MPS Shares Surge After Intesa Launches €30.6 Billion Offer

MPS Shares Surge After Intesa Launches €30.6 Billion Offer

8 June 2026
Banca Monte dei Paschi di Siena shares soared 10.91% to 9.921 euros after Intesa Sanpaolo launched an unsolicited €30.6 billion cash-and-share bid, offering a 12.5% premium and triggering takeover rules that block MPS from merging with Banco BPM without shareholder approval, as investors weigh regulatory hurdles, branch disposals, and the fight for control of key Italian financial assets.
Hyperscale Data Stock Faces 21-Cent Deadline After Friday’s 25% Slide

Hyperscale Data Stock Faces 21-Cent Deadline After Friday’s 25% Slide

8 June 2026
Hyperscale Data’s $0.21/share buyback offer sits 39% above Friday’s $0.1510 close, with the tender expiring late Monday and covering up to 5.1% of shares; the company cites a “material disconnect” with net book value at $0.26/share, while ending its ATM stock-sale program and holding $51.8M in Bitcoin as of May 31.
Zealand Pharma Shares Sink 25% After Trial Results

Zealand Pharma Shares Sink 25% After Trial Results

8 June 2026
Zealand Pharma shares plunged 26.02% to 241.40 Danish crowns after investors focused on a 19% discontinuation rate for Boehringer’s obesity drug survodutide in the SYNCHRONIZE-1 trial, far higher than the 2.9% for placebo, despite strong fat-loss data, making the stock the worst performer on Europe’s STOXX 600 in early trade.
Johnson & Johnson stock price: JNJ heads into Monday as Tremfya data lands and dividend date nears
Previous Story

Johnson & Johnson stock price: JNJ heads into Monday as Tremfya data lands and dividend date nears

National Grid share price ticks up as Ofgem flags AI data-centre power crunch
Next Story

National Grid share price ticks up as Ofgem flags AI data-centre power crunch

Go toTop